Nonselective (Random) Transfusions and Living Related Donor Specific Transfusions (DST) in Kidney Transplantation — NCD 93 | CMS Coverage Update

TL;DR: The Centers for Medicare & Medicaid Services modified NCD 93 governing pretransplant transfusion coverage in kidney transplantation, effective March 7, 2026. This policy does not list specific CPT or HCPCS codes, but it directly shapes how you document and bill for blood transfusions given to kidney transplant candidates under Medicare Part A.

Kidney transplant pretransplant transfusion billing just got a policy refresh under NCD 93 in the CMS Medicare system. The Centers for Medicare & Medicaid Services confirmed that both nonselective (random) transfusions and living-related donor specific transfusions (DST) remain covered without a set limit on the number of transfusions — but the blood deductible rules and how "replaced blood" is calculated matter enormously for your reimbursement. If your facility handles kidney transplant cases, this coverage policy deserves a close read before the effective date of March 7, 2026.

Quick-Reference Table

CMS Kidney Transplant Pretransplant Transfusion Coverage Criteria and Medical Necessity Requirements 2026

The clinical foundation of this coverage policy is well-established. Transplant surgeons have confirmed a direct correlation between pretransplant blood transfusions and the success of graft retention — in both cadaver and living-related kidney transplantation. CMS codified that finding in NCD 93, and the 2026 modification keeps that coverage intact.

Here is what medical necessity looks like under this policy. Pretransplant transfusions given to a kidney transplant recipient are covered under Medicare as inpatient hospital services. The policy sets no specific cap on the number of transfusions. That is the good news for facilities managing complex transplant candidates who need multiple transfusions before surgery.

The coverage policy applies to two distinct transfusion types. First, nonselective (random) transfusions — standard blood products given without regard to a specific donor match. Second, living-related donor specific transfusions, where blood from a related donor is given directly to the transplant recipient to improve graft compatibility. Both are covered. Both are subject to the Medicare blood deductible provisions.

The blood deductible is where billing teams need to pay close attention. Medicare's blood deductible requires beneficiaries (or a third party on their behalf) to either pay for or replace the first three pints of blood in a benefit period. But NCD 93 includes a specific rule for donor specific transfusions: when blood is given directly to the transplant patient — as in a DST — that blood is considered "replaced" for purposes of the blood deductible. That distinction changes how you calculate what the patient owes.

Whether kidney transplant pretransplant transfusions require prior authorization depends on your MAC's local guidelines. NCD 93 itself does not impose a prior authorization requirement. But check with your Medicare Administrative Contractor before assuming blanket approval — regional guidance can layer on top of national coverage determinations.

For full cross-reference details, CMS points billing teams to the Medicare General Information, Eligibility, and Entitlement Manual, Chapter 3, §20.5.4. Review that section alongside this NCD when you're working through claim-level questions.

Coverage Indications at a Glance

CMS Kidney Transplant Transfusion Billing Guidelines and Action Items 2026

The policy modification is effective March 7, 2026. Here is what your billing team should do before and after that date.

CPT, HCPCS, and ICD-10 Codes for Kidney Transplant Transfusions Under NCD 93

No Specific Codes Listed in NCD 93

This policy does not list specific CPT, HCPCS, or ICD-10 codes. That is not unusual for older NCDs — NCD 93 establishes coverage principles and deductible rules rather than code-level billing instructions.

For kidney transplant pretransplant transfusion billing, your coding team should apply standard transfusion and blood administration codes consistent with your facility's charge capture protocols and any guidance from your Medicare Administrative Contractor. Do not assume a code is covered or excluded based on NCD 93 alone — cross-reference with your MAC's local coverage determinations and the Medicare Physician Fee Schedule or IPPS as applicable.

Because no codes appear in the policy data, we are not listing a code table here. Fabricating codes would be worse than useless — it would create billing risk. If you need code-level guidance for kidney transplant transfusion claims, contact your MAC directly or work with your coding consultant.

The Real Issue with NCD 93

Here is the honest take on this policy change: the modification itself does not appear to dramatically alter the substantive coverage rules. Pretransplant transfusions were covered before, and they are covered now. The "replaced blood" rule for DSTs was already in place.

What this modification does is refresh and reaffirm a policy that had been sitting largely unchanged. That matters for a few reasons. First, it signals that CMS reviewed this NCD and decided the current framework still stands — no new restrictions, no new exclusions. Second, for billing teams who inherited these processes without deep institutional knowledge, this is a good moment to pressure-test your workflows.

The financial risk here is not dramatic per claim. But multiply a blood deductible miscalculation across a high-volume transplant program, and it becomes a material reimbursement issue. Audits on these cases are not common, but when they happen, documentation gaps are the usual failure point.

The absence of specific codes in this policy also creates a practical challenge. Without code-level guidance, billing teams have to rely on their MAC's local coverage determination guidance and their own coding expertise. That is not a problem CMS created with this modification — it has always been the case with NCD 93. But it means your kidney transplant transfusion billing process depends more on your MAC relationship than your average NCD.

If your program has not mapped its blood administration codes to this NCD and the related manual guidance, do that now. The effective date of March 7, 2026 is a clean forcing function to get it done.